Profile: ProMetic Life Sciences Inc (PLI.TO)

PLI.TO on Toronto Stock Exchange

1.22CAD
17 Apr 2014
Price Change (% chg)

$0.01 (+0.83%)
Prev Close
$1.21
Open
$1.22
Day's High
$1.23
Day's Low
$1.18
Volume
703,291
Avg. Vol
1,829,288
52-wk High
$1.65
52-wk Low
$0.27

Search Stocks
ProMetic Life Sciences Inc. (ProMetic) is a bio-pharmaceutical comnpany offering technologies for large-scale drug purification, drug development, proteomics, clinical diagnostics, and the elimination of pathogens, The Company focuses its activities in two segments: protein technologies and therapeutics. It develops therapeutics to treat blood-related disorders. Its protein technologies are used to remove pathogens from blood and extract and recover valuable proteins from plasma. The Company is developing products to treat anemia, neutropenia, cancer and autoimmune disease/inflammation, as well as certain nephropathies. ProMetic uses its Affinity Technology, which employs its Mimetic Ligand technology (chemical hooks that selectively recognize and bind to target biomolecules) to facilitate a variety of applications, where a target biomolecule requires purification or removal. In October 2009, it obtained a controlling stake in Pathogen Removal and Diagnostic Technologies Inc.

Company Address

ProMetic Life Sciences Inc

Bldg 15, 531 Boul. des Prairies
LAVAL   QC   H7V 1B7
P: +1450.7810115
F: +1450.7814477

Search Stocks